WO2003097594A1 - Process for preparing optically pure 3-hydroxy-pyrrolidine - Google Patents

Process for preparing optically pure 3-hydroxy-pyrrolidine Download PDF

Info

Publication number
WO2003097594A1
WO2003097594A1 PCT/KR2003/000995 KR0300995W WO03097594A1 WO 2003097594 A1 WO2003097594 A1 WO 2003097594A1 KR 0300995 W KR0300995 W KR 0300995W WO 03097594 A1 WO03097594 A1 WO 03097594A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxy
acid
group
pyrrolidine
preparing
Prior art date
Application number
PCT/KR2003/000995
Other languages
French (fr)
Inventor
Jongpil Chun
Jae Kwang Hwang
Seung Bum Ha
Yik-Haeng Cho
Ji Uk Yoo
Original Assignee
Samsung Fine Chemicals Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samsung Fine Chemicals Co., Ltd. filed Critical Samsung Fine Chemicals Co., Ltd.
Priority to AU2003230438A priority Critical patent/AU2003230438A1/en
Publication of WO2003097594A1 publication Critical patent/WO2003097594A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members

Definitions

  • the present invention relates to a method for preparing optically pure
  • vasodilators calcium antagonist: barnidipine
  • Patent Publication No. 391,169 European Patent Publication No. 304,087]
  • anodynes anodynes
  • Patent Publication No. Hei 4-164066 Japanese Patent Publication No. Sho 61-63652
  • this method uses B 2 H 6 , which is expensive and difficult to handle, as a
  • the present inventors have made enormous efforts to find a method for
  • optically pure target compound can be prepared in good yield.
  • an object of the present invention is to provide a method for
  • the preparing method according to the present invention comprises:
  • R 1 is an aryl or a substituted aryl group
  • R 2 is a hydrogen atom or an acyl
  • HX is halogen acid or aliphatic acid
  • Y is a halogen, a C ⁇ -C 2
  • alkylsulfonyloxy, arylsulfonyloxy or a substituted arylsulfonyloxy group alkylsulfonyloxy, arylsulfonyloxy or a substituted arylsulfonyloxy group.
  • the present invention relates to a method for preparing optically pure (S)- or
  • the first step is imination of reacting optically pure 3,4-epoxy-l-butanol
  • the starting material or optically pure (S)- or (R)-3,4-epoxy-l-butanol represented by Formula 2, can be prepared from commercially available
  • aldehyde compound used in the imination step aldehyde having an
  • aryl or a substituted aryl group preferably benzaldehyde, is used.
  • ammonia is used in 1 to 20 equivalents, preferably in 2 to 5
  • aldehyde compound is used in 1 to 5 equivalents, preferably in 1
  • an organic solvent or water may be used as a solvent.
  • the reaction time is 1 to 24 hours, and preferably 3 to 5 hours.
  • imino group is converted to amine in the presence of an acid catalyst simultaneously
  • the selective activation at C-1 of the present invention can be done by
  • any common halogenating agent can be any common halogenating agent.
  • the halogenating agent is used in 1 to 5
  • halogenation is proceeded at a temperature ranging from 20 to 60 °C , preferably 30 to
  • the reaction time is 1 to 24 hours, and preferably 3 to 6 hours.
  • alkylsulfonic acid anhydride alkylsulfonyl
  • methanesulfonyl chloride or p-toluenesulfonyl chloride can be used.
  • sulfonating agent is used in 1 to 3 equivalents, preferably in 1 to 2 equivalents.
  • aliphatic or aromatic amines preferably triethylamine
  • diisopropylethylamine or pyridine can be used.
  • the base is used in 1 to 3 equivalents, preferably in 1 to 2 equivalents.
  • an organic solvent preferably dichloromethane, dichloroethane,
  • reaction time is 1 to 12 hours
  • halogen acid or aliphatic acid preferably hydrochloric acid
  • hydrobromic acid acetic acid or methanesulfonic acid
  • the acid is used
  • reaction is proceeded at a
  • reaction time is 1 to 5
  • Formula 5 is accomplishing intramolecular cyclization in the presence of a base to
  • inorganic base or organic base can be used.
  • Inorganic base or organic base can be used.
  • alkali metal salt or alkali earth metal salt refers to alkali metal salt or alkali earth metal salt. To be specific, it includes
  • base refers to aliphatic or aromatic amine. To be specific, it includes alkylamine and
  • the base is used in 1 to 10 equivalents, preferably in 2 to 4 equivalents.
  • reaction solvent an organic solvent or water, preferably water, methanol or ethanol can be used.
  • the reaction is proceeded at a temperature ranging from 0 to
  • reaction time is 1 to 24 hours, and preferably 1 to 6
  • the preparing method of the present invention minimizes generation of
  • trimer are generated as by-products.
  • activation at C-1 can be done efficiently without by-products.
  • the concentrate was diluted in 500m ⁇ of dichloromethane and washed with 50ml of
  • dichloromethane layer was dried with anhydrous magnesium sulfate and
  • the reaction solution was cooled to room temperature and 150m£ of water was added.
  • the water layer was heated at 40 ° C for 1 hour for deacetylation. Then, the
  • target compound was distillated under reduced pressure and azotropically distillated
  • the reactor was heated to room temperature and stirred for 2 hours.
  • N-trifluoroacetyl-3-trifluoroacetoxy-pyrrolidine was synthesized as
  • the preparing method according to the present invention synthesizes
  • the target compound by selectively activating a hydroxy group at C-1. In this way, the target compound
  • the present invention can maximize productivity of optically

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a method for preparing optically pure 3-hydroxy-pyrrolidine, more particularly to a novel method for preparing 3-hydroxy-pyrrolidine economically, conveniently and efficiently, by reacting optically active 3,4-epoxy-1-butanol with ammonia and an aldehyde compound to prepare 4-protected-imino-butane-1,3-diol, selectively activating a hydroxy group at C-1 and then converting an imino group to an amine group by acid simultaneously or consecutively and performing intramolecular cyclization in the presence of a base.

Description

PROCESS FOR PREPARING OPTICALLY PURE 3-HYDROXY-PYRROLIDINE
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a method for preparing optically pure
3-hydroxy-pyrrolidine, more particularly to a novel method for preparing
3-hydroxy-pyrrolidine represented by the following Formula 1 economically,
conveniently and efficiently, by reacting optically active 3,4-epoxy-l-butanol with
ammonia and an aldehyde compound to prepare 4-protected-imino-butane-l,3-diol,
selectively activating a hydroxy group at C-1 and then converting an imino group to
an amine group by acid simultaneously or consecutively and performing
intramolecular cyclization in the presence of a base.
Figure imgf000002_0001
H (1)
In Formula 1, * represents (S) or (R) configuration.
Optically pure (S)- or (R)-3-hydroxy-pyrrolidine derivatives are used as
intermediate compounds for preparing a variety of chiral compounds. For example,
they are used as key intermediate materials for preparing chiral medicines, such as
vasodilators (calcium antagonist: barnidipine) [European Patent Publication No.
160,451, /. Med. Chem. 1986, 29, 2504-2511, Japanese Patent Publication No. Sho 61-267577, Japanese Patent Publication No. Sho 61-63652], carbapenem antibiotics
[Heterocji cles, vol 24, No 5, 1986, Tetrahedron Lett. 25, 2793, 1984, W088/ 08845, /. Org.
Chem. 1992, 57, 4352-4361], quinolone antibiotics [US Patent No. 4,916,141, European
Patent Publication No. 391,169, European Patent Publication No. 304,087], anodynes
(κ-receptor agonists) [European Patent Publication No. 398,720, European Patent
Publication No. 366,327, /. Med. Chem., 1994, 37, 2138-2144] and neurotransmitters
[WO01/ 19817].
Description of Related Art
The conventional methods for preparing optically pure (S)- or
(R)-3-hydroxy-pyrrolidine derivatives are as follows.
There is a method of preparing (R)-3-hydroxy-pyrrolidine by decarboxylation
using L-hydroxy-proline [Chem. Lett. 893, 1986, Syn. Commun. 23, 2691, 1993, Syn.
Commun. 24, 1381, 1994]. Disadvantage of this method is that it uses expensive
L-hydroxy-proline as a starting material.
There is a method of obtaining cyclized amide by multi-step from L-malic acid
or L-glutamic acid and reducing it with LiAlH4 or B2H6 [Syn. Commun. 15, 587-598,
1985, /. Med. Chem. 1994, 37, 2138-2144, Syn. Commun. 16, 1815-1822, 1986].
Disadvantage of this method is that it requires several steps and LiAlH4 or B2H6
reducing agents are expensive and difficult to handle.
There is a method of obtaining l-benzyl-3-hydroxy-pyrrolidine by preparing 4-halo-3-hydroxy-butanoate by reduction of β-ketoester using catalyst, reducing
with Ca(BH4)2, selectively activating hydroxy group to sulfonic acid derivative and
carrying out intramolecular cyclization [European Patent Publication No. 452,143].
Disadvantage of this method is that it requires an expensive catalyst and reduction
should be processed selectively only in one direction during induction of chiral center
at carbon.
There is a method of obtaining 3-hydroxy-pyrrolidine by preparing chiral C4
derivative through optical resolution of racemic C3 compound using an enzyme and
carbon chain elongation (KCN) and carrying out reduction in the presence of a metal
catalyst and intramolecular cyclization [European Patent Publication No. 347,818,
European Patent Publication No. 431,521]. This method also should be processed in
one direction during induction of chiral center at carbon.
There is a method of introducing a chiral hydroxy group by asymmetric
hydroboration of N-substituted-3-ρyrroline [/. Org. Chem. 1986, 51, 4296-4298, /. Am.
Chem. Soc, 1986,108, 2049]. However, this method is not yet commercially
applicable.
Also, there are classical optical resolution, hydrolysis using an enzyme and
esterification using an enzyme [Japanese Patent Publication No. Hei 5-32620, Japanese
Patent Publication No. Hei 4-164066, Japanese Patent Publication No. Sho 61-63652,
Bull. Chem. Soc. Jpn. 1996, 69, 207, Enantiomer, 1997, 2, 311-314, Biochem. 1995, 59, 1287].
But, theoretical maximum yield of these methods cannot exceed 50% irrespective of optical purity.
There is a method of obtaining 3-hydroxy-pyrrolidine by preparing
2-halo-l,4-butanediol through halogenation and B2H6 reduction of D- or L-aspartic
acid, preparing 4-methanesulfonyloxy-l,2-epoxybutane by epoxidation and
sulfonation and carrying out reaction with ammonia [Heterocycles, 1986, 24, 5].
Although the starting material of this method is similar to that of the present
invention, this method uses B2H6, which is expensive and difficult to handle, as a
reducing agent. Also, during the reaction with ammonia, which is the key process,
excess by-products are formed, so that the reaction yield is below 28%. And,
introduction of a protection group is required during the purification of
3-hydroxy-pyrrolidine.
As yet, a method preparing 3-hydroxy-pyrrolidine using 3,4-epoxy-l-butanol
as a starting material as disclosed in the present invention has not been known.
SUMMARY OF THE INVENTION
The present inventors have made enormous efforts to find a method for
preparing optically pure 3-hydroxy-pyrrolidine conveniently and economically.
As a result, they identified that: if optically active 3,4-epoxy-l-butanol is reacted with
ammonia and aldehyde compound, 4-protected imino-butane-l,3-diol is obtained as
an intermediate without a by-product, and then, through intramolecular cyclization
while selectively activating a hydroxy group at C-1 with a leaving group, optically pure target compound can be prepared in good yield.
Accordingly, an object of the present invention is to provide a method for
preparing commercially available optically pure 3-hydroxy-pyrrolidine in good yield
and in large quantity.
The preparing method according to the present invention comprises:
a step of reacting optically active 3,4-epoxy-l-butanol represented by the
following Formula 2 with ammonia and an aldehyde compound to obtain 4-protected
imino-butane-l,3-diol represented by the following Formula 3;
a step of selectively activating a hydroxy group at C-1 of the compound
represented by Formula 3 with a leaving group (halogen or sulfonyloxy group) by
halogenation or sulfonation to obtain an intermediate represented by the following
Formula 4, and treating it with an acid simultaneously or consecutively to obtain
3-hydroxy-l-substituted-butylamine salt represented by the following Formula 5; and
a step of intramolecular cyclizing the compound represented by Formula 5 in
the presence of a base to obtain 3-hydroxy-pyrrolidine represented by the following
Formula 1:
Scheme 1
Figure imgf000007_0001
Figure imgf000007_0002
wherein: R1 is an aryl or a substituted aryl group; R2 is a hydrogen atom or an acyl
group; HX is halogen acid or aliphatic acid; and Y is a halogen, a Cι-C 2
alkylsulfonyloxy, arylsulfonyloxy or a substituted arylsulfonyloxy group.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Hereinafter, the present invention is described in more detail.
The present invention relates to a method for preparing optically pure (S)- or
(R)-3-hydroxy-pyrrolidine from optically active (S)- or (R)-3,4-epoxy-l-butanol
effectively and economically without a by-product.
Each step of the preparing method of the present invention represented in
Scheme 1 is described in more detail in the followings.
The first step is imination of reacting optically pure 3,4-epoxy-l-butanol
represented by Formula 2 with ammonia and an aldehyde compound to obtain
4-protected-imino-butane-l,3-diol represented by Formula 3.
The starting material, or optically pure (S)- or (R)-3,4-epoxy-l-butanol represented by Formula 2, can be prepared from commercially available
(S)-3-hydroxy-γ-butyrolactone by known methods [Japanese Patent Publication No.
Hei 2-174733].
For the aldehyde compound used in the imination step, aldehyde having an
aryl or a substituted aryl group, preferably benzaldehyde, is used. In the
imination step: ammonia is used in 1 to 20 equivalents, preferably in 2 to 5
equivalents; and the aldehyde compound is used in 1 to 5 equivalents, preferably in 1
to 2 equivalents. This step proceeds well without using a reaction solvent. If
necessary, an organic solvent or water may be used as a solvent. The imination is
proceeded at a temperature ranging from 20 to 80 °C, preferably from 20 to 40 °C .
The reaction time is 1 to 24 hours, and preferably 3 to 5 hours.
In the second step of the present invention, a hydroxy group at C-1 of the
compound represented by Formula 3 is selectively activated to form the intermediate
represented by Formula 4, and it is treated with an acid simultaneously or
consecutively to convert an imino group to an amine group, thereby obtaining
3-hydroxy-l-substituted-butylamine salt represented by Formula 5. That is, a
hydroxy group at C-1 of the compound represented by Formula 3 is activated and the
imino group is converted to amine in the presence of an acid catalyst simultaneously
or in situ. Several selective activation methods similar to that of the present
invention are reported. However, they are about selective activation at C-1 of
1,3-butanediol or 3-benzyloxy-2-methylpropane-l,2-diol, different from the present invention [Tetrahedron: Asymmetry 12, 1383-1388, 2001, /. Org. Chem. 53, 4081-4084,
1988, /. Chem. Soc, Perkin Trans., 1973, 1214, Organic Sji nthesis, 63, 140].
The selective activation at C-1 of the present invention can be done by
halogenation or sulfonation.
In case the selective activation at C-1 is done by halogenation via the
intermediate represented by Formula 4, deprotection is carried out during water
addition for purification. In the halogenation, any common halogenating agent can
be used, and preferably hydrobromic acid. The halogenating agent is used in 1 to 5
equivalents, preferably in 2 to 3 equivalents. The halogenation can be proceeded
without a reaction solvent. If necessary, an organic solvent can be used. The
halogenation is proceeded at a temperature ranging from 20 to 60 °C , preferably 30 to
50 °C . The reaction time is 1 to 24 hours, and preferably 3 to 6 hours.
In case the selective activation at C-1 is done by sulfonation, an intermediate
represented by formula 4 can be purified or proceeded in situ depending on the
situation. For the sulfonating agents, alkylsulfonic acid anhydride, alkylsulfonyl
chloride or aryl sulfonyl chloride can be used. Specifically, G1-C12 alkylsulfonic acid
anhydride, alkylsulfonyl chloride or aryl sulfonyl chloride, preferably
methanesulfonyl chloride or p-toluenesulfonyl chloride, can be used. The
sulfonating agent is used in 1 to 3 equivalents, preferably in 1 to 2 equivalents.
For the base, aliphatic or aromatic amines, preferably triethylamine,
diisopropylethylamine or pyridine, can be used. The base is used in 1 to 3 equivalents, preferably in 1 to 2 equivalents. For the reaction solvent of the
sulfonation, an organic solvent, preferably dichloromethane, dichloroethane,
chloroform or dioxane, can be used. The reaction is proceeded at a temperature
ranging from -20 to 30 °C, preferably -10 to 10 °C . The reaction time is 1 to 12 hours,
and preferably 1 to 3 hours.
After the sulfonation is completed, the imino group is converted to an amine
group in the presence of an acid catalyst after purification, or in situ using an acid
catalyst. For the acid, halogen acid or aliphatic acid, preferably hydrochloric acid,
hydrobromic acid, acetic acid or methanesulfonic acid can be used. The acid is used
in 1 to 5 equivalents, preferably in 1 to 3 equivalents. The reaction is proceeded at a
temperature ranging from 5 to 40 °C, preferably 5 to 20 °C . The reaction time is 1 to 5
hours, and preferably 1 to 3 hours.
In the third step of the present invention, the compound represented by
Formula 5 is accomplishing intramolecular cyclization in the presence of a base to
obtain the compound represented by Formula 1, the target compound of the present
invention. For the base, inorganic base or organic base can be used. Inorganic base
refers to alkali metal salt or alkali earth metal salt. To be specific, it includes
hydroxide, alkoxide and carbonate of alkali metal or alkali earth metal. Organic
base refers to aliphatic or aromatic amine. To be specific, it includes alkylamine and
arylamine. The base is used in 1 to 10 equivalents, preferably in 2 to 4 equivalents.
For the reaction solvent, an organic solvent or water, preferably water, methanol or ethanol can be used. The reaction is proceeded at a temperature ranging from 0 to
80 °C , preferably 0 to 30 °C . The reaction time is 1 to 24 hours, and preferably 1 to 6
hours.
The preparing method of the present invention minimizes generation of
by-products and provides good yield.
In Synth. Commun., 1973, 3, 177, the compound represented by Formula 2 was
directly aminated to obtain 4-amino-butane-l,3-diol. That is, 3,4-epoxy-l-butanol
was treated with ammonia to aminate the C-4 position. However, if
3,4-epoxy-l-butanol represented by Formula 2 is reacted with ammonia, dimer and
trimer are generated as by-products.
Figure imgf000011_0001
On the other hand, the present invention prepares the compound represented
by Formula 5 from 3,4-epoxy-l-butanol by way of the imine intermediate represented
by Formula 3. Therefore, generation of a dimer or a trimer is prevented and the
production yield can be maximized.
Also, with the introduction of the protection group (imine), the selective
activation at C-1 can be done efficiently without by-products.
Hereinafter, the present invention is described in more detail through
Examples. However, the following examples are only for the understanding of the
present invention, and the present invention is not limited by the following Examples. In the examples, chirality is not marked distinctively.
Example 1: Preparation of 4-benzimino-butane-l,3-diol
3,4-Epoxy-l-butanol (100 g, 1.13 mol) was dissolved in 400m£ of ethanol in a
26 reactor. Benzaldehyde (121.6g, 1.15 mol) and 28% aqueous solution of ammonia
(275.6g, 4.54 mol) was added to the reactor, and the reactor was stirred at 40 °C for 3
hours. After the reaction was completed, the reaction mixture was cooled to room
temperature and the reaction solvent was concentrated under reduced pressure.
The concentrate was diluted in 500m^ of dichloromethane and washed with 50ml of
saturated brine. The dichloromethane layer was dried with anhydrous magnesium
sulfate and concentrated under reduced pressure to obtain 201.8g of target compound
(yield: 92%).
Η-NMR (CDCls, ppm) δ 1.85 (m, 2H), 3.2 (br, 1H), 3.63 (m, 1H), 3.74 (m, 1H), 3.88
(m, 2H), 4.16 (m, 1H), 7.36-7.73 (m, 5H), 8.33 (s, 1H)
Example 2: Preparation of 4-benzimino-3-hydroxy-l-methanesulf onyloxybutane
4-Benzimino-butane-l,3-diol (123g, 0.64 mol) was dissolved in όOOmβ of
dichloromethane in a 21 reactor, and the reaction solution was cooled to -10 °C .
Diisopropylethylamine (90.5g, 0.70 mol) was added at the same temperature, and
methanesulfonyl chloride (76.6g, 0.67 mol) was added dropwise for 1 hour keeping
the temperature at -10 °C . The reaction solution was stirred at the same temperature for 1 hour and warmed to 0°C to complete the reaction. 100 nι(. of water was
slowly added to the reaction solution at 0 to 5°C to wash it. Then, the
dichloromethane layer was dried with anhydrous magnesium sulfate and
concentrated under reduced pressure to obtain 152g of target compound (yield: 88%).
Η-NMR (CDCb, ppm) δ 1.93 (m, IH), 2.05 (m, IH), 3.05 (s, 3H), 3.57 (dd, IH), 3.76
(m, IH), 4.0 9(m, IH), 4.46 (m, 2H), 7.38-7.73 (m, 5H), 8.35 (s, IH)
Example 3: Preparation of 3-hydroxy-l-methanesulfonyloxy-butylamine hydrogen
chloride salt
The compound (lOOg, 0.37 mol) prepared in Example 2 was dissolved in 400m£
of dichloromethane and cooled to 5°C . 10% aqueous solution of hydrochloric acid
(269g, 0.74 mol) was added dropwise at 5°C for 1 hour while stirring the reaction
solution. The water layer was concentrated and azotropically distillated with
ethanol to obtain 77.7g of hydrogen chloride salt of target compound (yield: 96%).
Η-NMR (D20, ppm) δ 1.74 (m, IH), 1.88 (m, IH), 2.82 (m, IH), 3.03 (dd, IH), 3.89 (m,
IH), 4.32 (m, 2H)
Example 4: Preparation of 3-hydroxy-l-methanesulfonyloxy-butylamine hydrogen
chloride salt
The reaction according to Example 2 was carried out in situ, without
separation according to Example 3 to obtain 123. lg of hydrogen chloride salt of the target compound (yield: 88%).
Η-NMR (D20, ppm) δ 1.74 (m, IH), 1.88 (m, IH), 2.82 (m, IH), 3.03 (dd, IH), 3.89 (m,
IH), 4.32 (m, 2H)
Example 5: Preparation of 3-hydroxy-l-bromo-butylamine hydrogen bromide salt
4-Benzimino-butane-l,3-diol (100g, 0.52 mol) and 33% hydrobromic
acid-acetic acid solution (380.6g, 1.55 mol) were added in a 11 reactor, and the reactor
was sealed. The reactor was heated at 40 °C for 5 hours to complete the reaction.
The reaction solution was cooled to room temperature and 150m£ of water was added.
The reaction solution was stirred at the same temperature for 1 hour and
concentrated under reduced pressure. 300ιn£ of toluene was added to the
concentrate. After concentration under reduced pressure, toluene was added again,
and was then concentrated under reduced pressure once more. The concentrate was
dissolved in 600m^ of dichloromethane and 200ut£ of water, and the water layer was
separated. The dichloromethane layer was added to 200m of water and the water
layer was separated again. The combined water layers were washed with 200m£ of
dichloromethane, and the target compound in the water layer was analyzed.
The NMR analysis showed that the water layer contains
3-acetoxy-l-bromo-butylamine hydrogen bromide salt and
3-hydroxy-l-bromo-butylamine hydrogen bromide salt (4:6 ratio).
Η-NMR (D20, ppm) δ 2.03 (s, 3H), 2.12 (m, 2H), 3.12 (m, 2H), 3.34 (m, 2H), 5.18 (m, IH)
The water layer was heated at 40 °C for 1 hour for deacetylation. Then, the
target compound was distillated under reduced pressure and azotropically distillated
with ethanol to obtain 121.lg of hydrogen bromide salt of the target compound (yield:
94%).
Η-NMR (D20, ppm) δ 1.93 (m, 2H), 2.82 (m, IH), 3.03 (dd, IH), 3.46 (q, 2H), 3.95 (m,
IH)
Example 6: Preparation of 3-hydroxy-pyrrolidine
3-Hydroxy-l-methanesulfonyloxy-butylamine hydrogen chloride salt (70g,
0.32 mol) was dissolved in 400ra£ of methanol in a 11 reactor. The reactor was
cooled to 5°C. After slowly adding sodium hydroxide (38.2g, 0.96 mol) at the same
temperature, the reactor was heated to room temperature and stirred for 2 hours.
After the reaction was completed, the reaction solution was filtered and concentrated
under reduced pressure. Then, the concentrate was dissolved in 500ιιι£ of
dichloromethane. Undissolved material was removed with celite, and the solution
was concentrated under reduced pressure. The target compound was distilled
under reduced pressure of 0.2 torr at 65 °C to obtain 25.6g of pure target compound
(yield: 92%).
Η-NMR (CDC13, ppm) δ 1.72 (m, IH), 1.95 (m, IH), 2.79 (br, 2H), 2.86 (m, 3H), 3.12
(m, IH), 4.39 (m, IH) Example 7: Preparation of 3-hydroxy-pyrrolidine
3-Hydroxy-l-bromo-butylamine hydrogen bromide salt (lOOg, 0.40 mol) was
dissolved in 500ιn# of methanol in a 11 reactor. The reactor was cooled to 5°C.
After slowly adding sodium hydroxide (48.2g, 1.21 mol) at the same temperature, the
reactor was heated to room temperature and stirred for 1 hour. After the reaction
was completed, the reaction solution was filtered and concentrated under reduced
pressure. Then, the concentrate was dissolved in 600nι of dichloromethane.
Undissolved material was removed with celite, and the solution was concentrated
under reduced pressure. The target compound was distilled under reduced
pressure of 0.2 torr at 65 °C to obtain 30.4g of pure target compound (yield: 87%).
-NMR (CDC13, ppm) δ 1.72 (m, IH), 1.95 (m, IH), 2.79 (br, 2H), 2.86 (m, 3H), 3.12
(m, IH), 4.39 (m, IH)
Experimental Example 1: Optical purity analysis of (S)- or
(R)-3-hydroxy-pyrrolidine
To analyze optical purity of 3-hydroxy-pyrrolidine prepared by the present
invention, N-trifluoroacetyl-3-trifluoroacetoxy-pyrrolidine was synthesized as
follows.
50mg of 3-hydroxy-pyrrolidine (0.57 mmol) was dissolved in 5nt£ of
dichloromethane. Then, 362mg of trifluoroacetic anhydride (1.72 mmol) was added and the mixture was stirred at room temperature for 30 minutes. After the reaction
was completed, the reaction solution was evaporated and concentrated. After
adding 10ιιt£ of dichloromethane, the reaction solution was evaporated and
concentrated again to obtain N-rrifluoroacetyl-3-trifluoroacetoxy-pyrrolidine.
Η-NMR (CDC , ppm) δ 2.26-2.41 (m, 2H), 3.70-4.04 (m, 4H), 5.62 (m, IH)
Thus obtained N-trifluoroacetyl-3-trifluoroacetoxy-pyrrolidine was dissolved
in 5ιιt£ of dichloromethane. Then, l.O β of the sample was taken with a syringe and
then the optical purity was measured by GC analyzer.
The preparing method according to the present invention synthesizes
4-protected-imino-butane-l,3-diol intermediate from optically active
3,4-epoxy-l-butanol, as a starting material. Then, amine-induced
3-hydroxy-l-substituted-butylamine intermediate is prepared without by-products
by selectively activating a hydroxy group at C-1. In this way, the target compound
can be obtained conveniently and effectively.
Accordingly, the present invention can maximize productivity of optically
pure 3-hydroxy-pyrrolidine production.
While the present invention has been described in detail with reference to the
preferred embodiments, those skilled in the art will appreciate that various
modifications and substitutions can be made thereto without departing from the spirit and scope of the present invention as set forth in the appended claims.

Claims

CLAIMSWHAT IS CLAIMED IS:
1. A method of preparing 3-hydroxy-pyrrolidine, which comprises:
a) a step of reacting optically active 3,4-epoxy-l-butanol represented by the
following Formula 2 with ammonia and an aldehyde compound to obtain
4-protected- imino-butane-l,3-diol represented by the following Formula 3;
b) a step of halogenating or sulfonating the compound represented by
Formula 3 to selectively activate a hydroxy group at C-1 with a leaving group
(halogen or sulfonyloxy group) to prepare an intermediate represented by the
following Formula 4, and simultaneously or consecutively, treating the same with an
acid to obtain 3-hydroxy-l-substituted-butylamine salt represented by the following
Formula 5; and
c) a step of intramolecular cyclizing the compound represented by Formula 5
in the presence of a base to obtain 3-hydroxy-pyrrolidine represented by the
following Formula 1:
Figure imgf000020_0001
Figure imgf000020_0002
4 5 wherein: R1 is an aryl or a substituted aryl group; R2 is a hydrogen atom or an acyl
group; HX is halogen acid or aliphatic acid; and Y is a halogen, a G-C 2
alkylsulfonyloxy group, arylsulfonyloxy or substituted arylsulfonyloxy group.
2. The method preparing 3-hydroxy-pyrrolidine according to Claim 1, wherein said
imination is proceeded at a temperature ranging from 20 to 80 °C .
3. The preparing method according to Claim 1, wherein said selective
halogenation at C-1 is carried out using a halogenating agent.
4. The preparing method according to Claim 3, wherein the halogenation is
proceeded at a temperature ranging from 20 to 60 °C .
5. The preparing method according to Claim 1, wherein said selective
sulfonation at C-1 is carried out using alkylsulfonic acid anhydride, alkylsulfonyl chloride, arylsulfonyl chloride or substituted arylsulfonyl chloride.
6. The preparing method according to Claim 5, wherein said sulfonation is
proceeded at a temperature ranging from -20 to 30 °C in the presence of a base.
7. The preparing method according to Claim 6, wherein said sulfonation is
carried out using diisopropylethylamine as a base.
8. The preparing method according to Claim 1, wherein b) the deprotection
after the selective activation is proceeded at a temperature ranging from 5 to 40 °C in
the presence of acid.
9. The preparing method according to Claim 8, wherein said deprotection is
carried out using aqueous solution of halogen acid as an acid.
10. The preparing method according to Claim 1, wherein said intramolecular
cyclization is proceeded at a temperature ranging from 0 to 80 °C in the presence of a
base.
PCT/KR2003/000995 2002-05-20 2003-05-20 Process for preparing optically pure 3-hydroxy-pyrrolidine WO2003097594A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003230438A AU2003230438A1 (en) 2002-05-20 2003-05-20 Process for preparing optically pure 3-hydroxy-pyrrolidine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0027878 2002-05-20
KR10-2002-0027878A KR100461569B1 (en) 2002-05-20 2002-05-20 Process for producing optically pure 3-hydroxy-pyrrolidine

Publications (1)

Publication Number Publication Date
WO2003097594A1 true WO2003097594A1 (en) 2003-11-27

Family

ID=29546311

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/000995 WO2003097594A1 (en) 2002-05-20 2003-05-20 Process for preparing optically pure 3-hydroxy-pyrrolidine

Country Status (3)

Country Link
KR (1) KR100461569B1 (en)
AU (1) AU2003230438A1 (en)
WO (1) WO2003097594A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007024113A1 (en) * 2005-08-25 2007-03-01 Rstech Corporation Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity
US7652152B2 (en) 2005-07-20 2010-01-26 Chiroad Incorporate Synthetic method of optically pure (S)-3-hydroxypyrrolidine
EP4382529A1 (en) 2022-12-07 2024-06-12 Bayer Consumer Care AG A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347818A2 (en) * 1988-06-22 1989-12-27 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing 3-pyrrolidinol
EP0431521A1 (en) * 1989-12-02 1991-06-12 Kanegafuchi Chemical Industry Co., Ltd. Aminobutanol derivative and process for the preparation of 3-pyrrolidinol from the same
US5187094A (en) * 1989-09-06 1993-02-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Method for the preparation of optically active 3-hydroxypyrrolidine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756457A (en) * 1980-08-14 1982-04-05 Koei Chem Co Ltd Preparation of 3-pyrrolidinol
JPS60104061A (en) * 1983-11-08 1985-06-08 Sankyo Co Ltd Preparation of pyrrolidine derivative
JPH0776209B2 (en) * 1990-04-11 1995-08-16 高砂香料工業株式会社 Process for producing optically active 3-hydroxypyrrolidine derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347818A2 (en) * 1988-06-22 1989-12-27 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing 3-pyrrolidinol
US5187094A (en) * 1989-09-06 1993-02-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Method for the preparation of optically active 3-hydroxypyrrolidine derivatives
EP0431521A1 (en) * 1989-12-02 1991-06-12 Kanegafuchi Chemical Industry Co., Ltd. Aminobutanol derivative and process for the preparation of 3-pyrrolidinol from the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7652152B2 (en) 2005-07-20 2010-01-26 Chiroad Incorporate Synthetic method of optically pure (S)-3-hydroxypyrrolidine
WO2007024113A1 (en) * 2005-08-25 2007-03-01 Rstech Corporation Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity
EP4382529A1 (en) 2022-12-07 2024-06-12 Bayer Consumer Care AG A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride
WO2024121219A1 (en) 2022-12-07 2024-06-13 Bayer Consumer Care Ag A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride

Also Published As

Publication number Publication date
KR100461569B1 (en) 2004-12-14
AU2003230438A1 (en) 2003-12-02
KR20030089949A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
Barluenga et al. 1, 3-Amino alcohols from 4-amino-1-aza dienes. Diastereo-and enantioselective approach to the four diastereoisomers of the N-terminal amino acid component of nikkomycins B and BX
Fukuyama et al. Stereocontrolled total synthesis of (.+-.)-quinocarcin
Kasahara et al. Asymmetric total synthesis of (+)-negamycin and (-)-3-epinegamycin via enantioselective 1, 3-dipolar cycloaddition
EA019431B1 (en) Process and intermediates for preparing integrase inhibitors
TWI438188B (en) Production method of intermediate compound for synthesizing medicament
US6566525B1 (en) Preparation of N-substituted-hydroxycycloalkylamine derivatives
Alcaide et al. Preparation of. alpha.-Methylene and. alpha.-Ethylidene. beta.-Lactams via the Ester Enolate-Imine Condensation Using. beta.-(Dialkylamino) Esters as Starting Materials: Scope and Synthetic Applications
WO2003097594A1 (en) Process for preparing optically pure 3-hydroxy-pyrrolidine
JP5301676B2 (en) Process for producing (3S, 4S) -4-((R) -2- (benzyloxy) tridecyl) -3-hexyl-2-oxetanone and novel intermediate used therefor
Lee et al. Efficient synthesis of 3-hydroxyprolines and 3-hydroxyprolinols from sugars
WO2006075778A1 (en) Production method of optically active cyclohexane ether compounds
EP0906314A1 (en) Optical resolution of narwedine-type compounds
AU759441B2 (en) Process for the production of paroxetine
US20040073045A1 (en) Pyrrolidine derivative and process for producing the same
US5670666A (en) Process for preparing intermediates for the synthesis of D1 antagonists
US7842818B2 (en) Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof
EP1375465A1 (en) Cyclooctanone derivative and cyclodecanone derivative, and use thereof
WO2007132990A1 (en) Process for the preparation of chiral glycidylphthalimide in highly optical purity
US5300660A (en) Efficient stereoconservative synthesis of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines and intermediates thereto
US6388083B2 (en) Process for the synthesis of (2S)-phenyl-3-piperidone
KR100856133B1 (en) Improved process for preparing atorvastatin
KR100230900B1 (en) Pyrrolidine derivatives and process for preparing the same
Yamauchi et al. Diastereoselective addition of organolithiums to 1, 3-oxazolidines complexed with aluminum tris (2, 6-diphenylphenoxide)(ATPH)
JP2002284761A (en) Optically active 3-aminopyrrolidine-2,5-dione derivative and method of producing optically active 3- aminopyrrolidine derivative
KR20240024937A (en) Method for producing CYP11A1 inhibitors and intermediates thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP